Clinical Trial Update: The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults [NA]

View source ↗

Summary

A completed clinical trial studying the effects of the dietary supplement CardioFlex Q10 on cardiovascular disease risk factors in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Abnormalities
• Cardiovascular Diseases
• Hypertension
• Myocardial Infarction
• Stroke

Drugs mentioned

• CardioFlex Q10 (Coenzyme Q10 (ubiquinone) supplement)

Snippet

Sponsor: University of Manitoba | Conditions: Cardiovascular Diseases, Cardiovascular Abnormalities | NA | Status: COMPLETED | Results posted: 2020-10-29